43742-0015 NDC - BIOLOGICAL COMPLEX (ANTHRACINUM, ARSENICUM ALBUM, BOTULINUM, CALCAREA HYPOPHOSPHOROSA, COXIELLA BURNETII, DYSENTERY BACILLUS, FRANCISELLA TULARENSIS, GAERTNER BACILLUS, KALI SULPHURICUM, LAC CANINUM, MALARIA OFFICINALIS, MUTABILE BACILLUS, PERTUSSINUM, PESTINUM, PYROGENIUM, TYPHOID FEVER,)

Drug Information

Product NDC: 43742-0015
Proprietary Name: Biological Complex
Non Proprietary Name: Anthracinum, Arsenicum album, Botulinum, Calcarea hypophosphorosa, Coxiella burnetii, Dysentery bacillus, Francisella tularensis, Gaertner bacillus, Kali sulphuricum, Lac caninum, Malaria officinalis, Mutabile bacillus, Pertussinum, Pestinum, Pyrogenium, Typhoid fever,
Active Ingredient(s): 30 [hp_C]/mL ARSENIC TRIOXIDE; 30 [hp_C]/mL BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; 30 [hp_C]/mL BOTULINUM TOXIN TYPE A; 30 [hp_C]/mL CALCIUM HYPOPHOSPHITE; 30 [hp_C]/mL CANIS LUPUS FAMILIARIS MILK; 30 [hp_C]/mL COXIELLA BURNETII; 30 [hp_C]/mL ESCHERICHIA COLI; 30 [hp_C]/mL FRANCISELLA TULARENSIS; 30 [hp_C]/mL HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; 30 [hp_C]/mL PLASMODIUM MALARIAE; 30 [hp_C]/mL POTASSIUM SULFATE; 30 [hp_C]/mL RANCID BEEF; 30 [hp_C]/mL SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; 30 [hp_C]/mL SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; 30 [hp_C]/mL SHIGELLA DYSENTERIAE; 30 [hp_C]/mL YERSINIA PESTIS
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Pharmacy Class(es): Acetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]

Labeler Information

Field Name	Field Value
Labeler Name:	Deseret Biologicals, Inc.
Product Type:	HUMAN OTC DRUG
FDA Application Number:
Marketing Category:	UNAPPROVED HOMEOPATHIC
Start Marketing Date:	4/26/2012

Package Information

No.	Package Code	Package Description	Billing Unit
1	43742-0015-1	30 mL in 1 BOTTLE, DROPPER (43742-0015-1)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	43742-0015	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	HUMAN OTC DRUG	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAME	Biological Complex	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIX	III	A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAME	Anthracinum, Arsenicum album, Botulinum, Calcarea hypophosphorosa, Coxiella burnetii, Dysentery bacillus, Francisella tularensis, Gaertner bacillus, Kali sulphuricum, Lac caninum, Malaria officinalis, Mutabile bacillus, Pertussinum, Pestinum, Pyrogenium, Typhoid fever,	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	LIQUID	The translation of the dosage form Code submitted by the firm.
ROUTE NAME	ORAL	The translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE	4/26/2012	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	UNAPPROVED HOMEOPATHIC	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	Deseret Biologicals, Inc.	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	ARSENIC TRIOXIDE; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BOTULINUM TOXIN TYPE A; CALCIUM HYPOPHOSPHITE; CANIS LUPUS FAMILIARIS MILK; COXIELLA BURNETII; ESCHERICHIA COLI; FRANCISELLA TULARENSIS; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; PLASMODIUM MALARIAE; POTASSIUM SULFATE; RANCID BEEF; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SHIGELLA DYSENTERIAE; YERSINIA PESTIS	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30
ACTIVE INGRED UNIT	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
PHARM CLASSES	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]

Drug Information

Labeler Information

Package Information

NDC Record

Download Record